Oral antithrombotic drugs benign prostate hyperplasia

Administration Oral Fibrinolytic Agents/*administration & dosage Humans Lasers Solid-State Male Prostatic Hyperplasia Risk Factors Antithrombotic Benign prostate hyperplasia (BPH) Holmium laser enucleation of the prostate (HoLEP) Perioperative safety

Administration Oral Chronic Disease Flowers/physiology Humans Male Medicine Traditional Phytotherapy Plant Extracts/*administration & dosage Pollen/*physiology Prostatic Hyperplasia/drug therapy Prostatitis/drug therapy Treatment Outcome clinical practice efficacy evidence-based complementary and alternative medicine phytotherapy pollen review

AE adverse event FSP first sleep period ICIQ-N International Consultation on Incontinence Questionnaire-Nocturia ICS International Continence Society Luts NP nocturnal polyuria NPI Nocturnal Polyuria Index Nocturia Nocturnal polyuria Oral desmopressin PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses PVR post-void residual urine volume RCT randomised controlled trial